BioXcel Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BTAI and other ETFs, options, and stocks.

About BTAI

BioXcel Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of artificial intelligence solutions in neuroscience and immuno-oncology. It also focuses on utilizing technology and research to develop therapeutics solutions. 

CEO
Vimal D. Mehta
CEOVimal D. Mehta
Employees
29
Employees29
Headquarters
New Haven, Connecticut
HeadquartersNew Haven, Connecticut
Founded
2017
Founded2017
Employees
29
Employees29

BTAI Key Statistics

Market cap
27.94M
Market cap27.94M
Price-Earnings ratio
-0.13
Price-Earnings ratio-0.13
Dividend yield
Dividend yield
Average volume
436.13K
Average volume436.13K
High today
$0.9126
High today$0.9126
Low today
$0.84
Low today$0.84
Open price
$0.85
Open price$0.85
Volume
337.49K
Volume337.49K
52 Week high
$8.08
52 Week high$8.08
52 Week low
$0.7365
52 Week low$0.7365

Stock Snapshot

As of today, BioXcel Therapeutics(BTAI) shares are valued at $0.90. The company's market cap stands at 27.94M, with a P/E ratio of -0.13.

On 2026-08-07, BioXcel Therapeutics(BTAI) stock traded between a low of $0.84 and a high of $0.91. Shares are currently priced at $0.90, which is +7.7% above the low and -0.8% below the high.

The BioXcel Therapeutics(BTAI)'s current trading volume is 337.49K, compared to an average daily volume of 436.13K.

During the past year, BioXcel Therapeutics(BTAI) stock moved between $0.74 at its lowest and $8.08 at its peak.

During the past year, BioXcel Therapeutics(BTAI) stock moved between $0.74 at its lowest and $8.08 at its peak.

BTAI News

TipRanks 1d
BioXcel’s BXCL501 Agitation Study Completion: What Investors Should Watch Next

Bioxcel Therapeutics (BTAI) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more co...

TipRanks 4d
BioXcel Therapeutics Amends Credit Agreement, Extends Debt Deadline

Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...

People also own

Based on the portfolios of people who own BTAI. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.